Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Expensive Performer
1028.1000 4.20 (0.41%)
NSE Apr 23, 2025 15:31 PM
Volume: 46,508
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
1028.10
0.41%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences.. has an average target of 939.00 from 3 brokers.
More from Alivus Life Sciences Ltd.
Recommended
Market closes higher, PNC Infratech bags a Rs 240 crore order from PWD, Rajasthan
Trendlyne Marketwatch | 23 Apr 2025, 03:56PM
Five stocks to buy from analysts this week - April 22, 2025
The Baseline | 22 Apr 2025, 05:59PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021